Australia, Nov. 12 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘Feasibility of Vaporised nicotine products in an alcohol and drug Inpatient unit: A Pilot Study’. The following are the other relevant details related to the trial:
Trial ID: 392814
Submit Date: 10/13/26 8:45
Study Type: Interventional
Intervention: Patients in an inpatient alcohol and drug withdrawal unit will be offered vaporised nicotine products (20mg/2ml; 35mg/2ml; 50mg/2ml) as required during their admission.
Participants who smoke 10 cigarettes per day or use their first nicotine product after 5 minutes and within 30 minutes of wakening will be recommended 35mg strength.
Participants who currently u...